Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder.

Source: Diabetes cure possibility being tested by Johnson & Johnson, ViaCyte | abc7chicago.com